Dawn Svoronos, Director at Xenon Pharmaceuticals Inc. (XENE), bought 50,000 shares at $2.82 ($141K) on 2017-08-14, disclosed to the SEC on 2017-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| GBT | SELL | 2022-06-22 | $104K | — | Filing → |
| PTCT | SELL | 2022-06-10 | $20K | — | Filing → |
| ADVM | BUY | 2022-05-18 | $26K | — | Filing → |